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Dengue virus (DENV) is responsible for the most prevalent arthropod-borne viral infection in humans. Events
decisive for disease development occur in the skin after virus inoculation by the mosquito. Yet, the role of human
dermis–resident immune cells in dengue infection and disease remains elusive. Here we investigated how dermal
dendritic cells (dDCs) and macrophages (dMs) react to DENV and impact on immunopathology. We show that
both CD1cþ and CD14þ dDC subsets were infected, but viral load greatly increased in CD14þ dDCs upon IL-4
stimulation, which correlated with upregulation of virus-binding lectins Dendritic Cell–Specific Intercellular
adhesion molecule-3–Grabbing Nonintegrin (DC-SIGN/CD209) and mannose receptor (CD206). IL-4 also
enhanced T-cell activation by dDCs, which was further increased upon dengue infection. dMs purified from
digested dermis were initially poorly infected but actively replicated the virus and produced TNF-a upon lectin
upregulation in response to IL-4. DC-SIGNþ cells are abundant in inflammatory skin with scabies infection or
Th2-type dermatitis, suggesting that skin reactions to mosquito bites heighten the risk of infection and
subsequent immunopathology. Our data identify dDCs and dMs as primary arbovirus target cells in humans
and suggest that dDCs initiate a potent virus-directed T-cell response, whereas dMs fuel the inflammatory
cascade characteristic of dengue fever.
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INTRODUCTION
The skin is the portal to infectious pathogens, in particular
those transmitted by biting insects. Dengue virus (DENV) is a
positive-strand RNA virus that belongs to the Flavivirus genus
of the flaviviridae family and is transmitted by Aedes mosqui-
toes. The virus is responsible for the most prevalent arthropod-
borne viral infection in humans, with an estimate of 390
million cases per year worldwide (Bhatt et al., 2013). Infec-
tion with DENV results in a wide spectrum of clinical
manifestations ranging from mild, undifferentiated fever to
hemorrhage and hypovolemic shock, which can be fatal if
untreated (Rigau-Perez et al., 1998). The global health burden
of dengue infections is likely to further increase through
sustained travel and vector spread; yet, efficient drugs or
vaccines are currently unavailable. It is widely believed that
the immune response mounted against the virus greatly
contributes to pathogenesis (Green and Rothman, 2006;
Mongkolsapaya et al., 2003; Pang et al., 2007); yet, our
incomplete comprehension of the etiology of DENV-mediated
diseases represents a serious hurdle to clinical prognosis and
therapeutic action. A level of complexity in the understanding
of arbovirus infection is introduced by the insect vector itself.
Mosquito salivary proteins trigger Th2 polarization (Cox et al.,
2012; Espada-Murao and Morita, 2011; Thangamani et al.,
2010) and cause allergic skin reaction (Peng and Simons,
2007). Insect saliva enhances infection of a number of insect-
vectorized pathogens including Dengue virus (Cox et al.,
2012; Styer et al., 2011). Moreover, inflammatory skin
manifestations are observed during an ongoing dengue
infection (Saleem and Shaikh, 2008).
DENV, like many other pathogens, enters cells through
carbohydrate-binding receptors that normally enable DCs
and macrophages (Ms) to sample antigens (Navarro-Sanchez
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et al., 2003; Tassaneetrithep et al., 2003; van Kooyk and
Geijtenbeek, 2003). Thus, monocyte-derived DCs and
monocyte-derived Ms that carry the C-type lectins Dendritic
Cell–Specific Intercellular adhesion molecule-3–Grabbing
Nonintegrin (DC-SIGN/CD209) and Mannose Receptor (MR/
CD206) are productively infected by DENV (Miller et al.,
2008; Navarro-Sanchez et al., 2003; Tassaneetrithep et al.,
2003). They then release inflammatory cytokines such as
tumor necrosis factor-a (TNF-a), which is thought to initiate
an inflammatory cascade leading to Dengue (hemorrhagic)
fever (Chen et al., 2008; Chen and Wang, 2002; Kwan et al.,
2005; Nightingale et al., 2008). Evidence that DC-SIGN has
an important role in immunopathology was provided by the
study of gene promoter polymorphism, showing that higher
DC-SIGN levels increase the risk of developing Dengue fever
(Sakuntabhai et al., 2005).
Although the skin is the portal to arboviruses, whether
skin-resident immune cells mediate DENV entry and impact
on immunopathology remains incompletely understood.
The epithelium-resident DCs, known as Langerhans cells
(LCs), were shown to be infected (Wu et al., 2000); yet,
these cells lack DC-SIGN and MR. Because dermal DCs
(dDCs) and dermal Ms (dMs) express these receptors and
represent plausible targets of DENV (Angel et al., 2006;
Harman et al., 2013; Ochoa et al., 2008; Zaba et al., 2007),
elucidation of their role in DENV infection and pathology
will help open new ways to disease prediction, vaccines,
and treatments.
RESULTS
Cutaneous reactions increase the risk of infection by
accumulation of DC-SIGNþ cells
We first assessed the risk of skin infection by determining the
presence of cells expressing the C-type lectin DC-SIGN, an
important DENV cell receptor (Navarro-Sanchez et al., 2003;
Tassaneetrithep et al., 2003). We compared the frequency of
DC-SIGNþ cells in normal skin and, because mosquito-bitten
skin is difficult to obtain, in skin lesions that resemble
reactions to mosquito bites. Hence, we studied the skin from
bullous pemphigoid, hypereosinophilic syndrome, masto-
cytosis, and scabies. These inflammations share with
mosquito bites a number of features such as basophil recruit-
ment and eosinophilia (Ito et al., 2011). DC-SIGN expression
was determined in combination with the CD163 marker,
which is stably expressed by dMs and CD14þ dDCs in
different inflammatory milieus (Fuentes-Duculan et al., 2010;
Haniffa et al., 2009; Pettersen et al., 2011; Zaba et al., 2007).
Cross sections were labeled for CD163 and DC-SIGN
(Figure 1a), and the cells exhibiting different combinations of
markers (CD163þ DC-SIGN , CD163 DC-SIGNþ , and
CD163þ DC-SIGNþ ) were counted (Figure 1b). DC-SIGN
was predominantly expressed by CD163þ myeloid cells both
in normal and in inflamed skin. Only in mastocytosis did we
see a population that expressed solely DC-SIGN. The mean
number of CD163þ DC-SIGNþ cells doubled from 24 to 51
per 0.125 mm2 in bullous pemphigoid and mastocytosis and
tripled to 78 in the hypereosinophilic syndrome and scabies.
Therefore, these findings show that normal skin is vulnerable
to DENV infection because it comprises DENV cell targets,
and inflammation arising as a cutaneous reaction to insect
bites heightens the infectious risk through increased numbers
of DC-SIGNþ dDCs or dMs.
dDC subsets are permissive to DENV infection
The human dermis contains CD14þ Ms, CD1a/cþ , and
CD141Hi dDCs (Angel et al., 2006; Chu et al., 2012;
Haniffa et al., 2009; Haniffa et al., 2012; Nestle et al.,
1993). The latter subset was not studied because they consti-
tute a very rare population. In addition, the dermis includes
another CD14þ migratory subset, which we will refer to as
CD14þ dDCs according to their original classification,
although recent investigations have demonstrated their
proximity to monocytes rather than DCs (McGovern et al.,
2014). We isolated a suspension of immune cells from normal
skin, comprising dDC subsets, as well as LCs and T cells,
following their spontaneous migration from skin explants into
culture medium (Nestle et al., 1993; Figure 2a). In comparison
with CD1cþ dDCs, the CD14þ dDCs expressed lower levels
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Figure 1. Increased Dendritic Cell–Specific Intercellular adhesion molecule-
3–Grabbing Nonintegrin (DC-SIGN) expression in dermatitis. (a) Images of
normal and hypereosinophilic syndrome skin stained for CD163 and DC-SIGN
with DAPI (40,6-diamidino-2-phenylindole) nuclear counterstain. The dotted
line marks the dermo–epidermal junction. Scale bars are shown.
(b) Graph depicts the number of CD163þ (red), DC-SIGNþ (green), and
CD163þ / DC-SIGNþ (brown) cells per field for each condition. The data
present the mean value±SD for five donors. The Wilcoxon test was used
for statistical analysis; **Po0.01.
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of HLA-DR, more MR, and exclusively DC-SIGN, in accor-
dance with previous findings (Harman et al., 2013; Ochoa
et al., 2008; Figure 2b). We assessed DENV infection by
exposing unseparated DCs to insect cell-produced DENV
(strain 16681, serotype 2) at a multiplicity of infection of
0.5. Viral load was measured after 2 days for each subset by
intracellular DENV-E protein labeling and flow cytometry
based on HLA-DR and CD14 expression (Figure 2c). Both
the HLA-DRhi CD14 and the HLA-DRlo CD14þ subsets
were infected by the pathogen. We verified viral accumulation
by confocal microscopy and observed DENV-E protein in
HLA-DRlo CD14þ DCs (Figure 2d). There was a vesicle-like
distribution of the protein with partial overlap with CD14 and
HLA-DR markers, suggesting an association of the virus with
the exocytic pathway. To better distinguish between infection
of CD1cþ dDCs, CD14þ dDCs, and LCs, we used a comple-
mentary gating strategy based on Langerin, DC-SIGN, and
differences in HLA-DR expression (Supplementary Fig. 1a).
We found that the CD14þ subset (Langerin DC-SIGNþ
HLA-DRlo) carried the highest viral load (mean±SD:
12.91%±7.35), followed by CD1cþ dDCs (Langerin DC-
SIGNlo HLA-DRhi; 7.75%±4.30) and LCs (Langerinþ HLA-
DRhi; 1.76%±2.29; Supplementary Figure 1c). Hence, dDCs
are infectious targets for DENV.
IL-4 stimulates productive infection of CD14þ dDCs
Arbovirus infectivity and pathogenicity have been correlated
with Th2-type immune reactions provoked by mosquito
salivary compounds (Cox et al., 2012; Styer et al., 2011).
Th2-type immunity is characterized by the release of IL-4 by
basophils, mast cells, and T cells. We therefore investigated
the impact of IL-4 on DC infection. To this end, we allowed
DCs to migrate into a medium lacking or containing IL-4,
harvested the cells, and exposed them to DENV. Two days
later, viral titers were determined. As shown in Figure 3a, the
viral titer was significantly elevated when DCs were condi-
tioned by IL-4. To determine whether the increased viral
production was the result of higher infection of one particular
DC subset, we determined the intracellular of DENV-E protein
content in each subset by flow cytometry. We found a greatly
increased viral load in IL-4-stimulated CD14þ dDCs but not
in CD1cþ dDCs or LCs (Figure 3b; Supplementary Figure 1b
and c). Visual inspection by confocal microscopy showed
DENV-E protein evenly distributed throughout the cytoplasm
of HLA-DRlo CD14þ dDCs, whereas HLA-DRhi CD14 DCs
were devoid of intracellular E protein (Figure 3c). Because IL-4
stimulates DC-SIGN and MR synthesis (Relloso et al., 2002),
we determined expression of these lectins in both dDC
subsets. Indeed, IL-4 triggered an upregulation of DC-SIGN
and MR on CD14þ dDCs but not on CD1cþ dDCs
(Figure 3d). Therefore, the presence of IL-4 strongly enhances
DENV infection of the CD14þ dDC subset, reflecting its
higher DC-SIGN and MR levels.
IL-4-activated dMs are infected by DENV
We next examined whether DENV infects dMs. As dMs are
non-migratory, enzymatic digestion was necessary to isolate
the cells from the tissue (Angel et al., 2006; Zaba et al., 2007).
After culturing the dermal cell suspension for 2 days,
CD14þHLA-DRþ cells were purified by flow cytometric
cell sorting (Supplementary Figure 2). Electron microscopy
showed that the purified cells displayed typical dM morphol-
ogy with melanin-loaded vesicles and few cell membrane
protrusions, in contrast to DCs (Figure 4a, left and right; Lenz
et al., 1993). Analysis of cell surface markers disclosed that
dMs expressed high levels of CD14 and HLA-DR but
surprisingly little DC-SIGN and MR (Figure 4b, condition
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Figure 2. Dermal dendritic cells (DCs) are infected by Dengue virus (DENV).
(a) DCs and T cells emigrating from skin explants were identified by FACS.
CD14 and CD1c labeling was determined on the gated DC-containing
population. (b) HLA-DR, MR, and Dendritic Cell–Specific Intercellular
adhesion molecule-3–Grabbing Nonintegrin (DC-SIGN) expression was
measured on gated CD14þ dermal DCs (dDCs) (green) and CD1cþ dDCs
(red). Isotype staining is in black. Data are representative of at least five donors.
(c) DENV infection of CD1a/cþ DCs (HLA-DRhiCD14 ) and CD14þ dDCs
(HLA-DRloCD14þ ) was measured by FACS as intracellular staining of DENV-E
protein. The mean percentage±SD (n¼ 7) of cells positive for DENV-E protein
in comparison to mock-infection is indicated. (d) Confocal microscopic
visualization of DENV-E protein within a CD14þ dDC. Scale bar represents
10mm. The image is representative of two donors.
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without cytokines). As this may be attributable to enzymatic
digestion or to cell dedifferentiation after isolation from the
skin, we searched for conditions that would restore DC-SIGN
and MR expression. In view of the stimulatory effect of IL-4 on
CD14þ DCs, we cultured the cell suspension for 2 days with
IL-4. In addition, because we had previously found that also
IL-10 induced DC-SIGN expression on monocytes, we cul-
tured the cells in IL-10 (Kwan et al., 2008). DC-SIGN and MR
levels clearly increased in response to IL-4; however, IL-10
had no effect (Figure 4b). To further enhance lectin levels, we
exposed dMs to IL-4 and GM-CSF, which resulted in a boost of
DC-SIGN and MR levels (Figure 4b). Concomitantly, HLA-DR
expression increased, whereas CD14 levels dropped. The cells
developed a DC-like morphology with more cytoplasmic
extensions but fewer phagosomes reminiscent of DCs
(Figure 4a). We then assessed DENV infection of dMs obtained
without cytokines, with IL-4 and with IL-4/GM-CSF by expos-
ing the purified cells to DENV, followed after 2 days by intra-
cellular DENV-E protein flow cytometric analysis. Untreated
dMs were poorly infected, but IL-4-stimulated dMs became
highly permissive to DENV, which was further enhanced
by GM-CSF (Figure 4c). Thus, dMs are infectious targets
for DENV when they express the viral-attachment lectins
DC-SIGN and MR.
DENV-infected dMs release TNF-a, and IL-4 enhances the
immunostimulatory function of dDCs
To evaluate the impact of DENV infection of dDCs and dMs
on dengue disease development, we determined their poten-
tial to stimulate the immune response. Given its cardinal role
in dengue pathologies, we first determined the production of
TNF-a. Except for one donor, there was very little TNF-a
released by virus-infected dDCs. Moreover, IL-4 could not
elevate its production (Figure 5a). On the other hand, TNF-a
was produced by dMs, in particular when activated with IL-4
or with IL-4/GM-CSF, reflecting increased viral load
(Figure 5b). Next, we evaluated whether IL-4 affected the
ability of dDCs and dMs to stimulate helper T cells. For this,
we performed mixed lymphocyte reactions with allogeneic
naive CD4þ T cells. We found that IL-4 enhanced the T-cell
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Figure 3. IL-4 stimulates Dengue Virus (DENV) infection of CD14þ dermal dendritic cells (dDCs). (a) Viral titers from mock- or DENV-infected DCs stimulated
or not by IL-4 were determined on Vero cells as FACS infectious units (FIU) per ml. Each point represents one donor and the horizontal bar the mean value.
(b) DENV infection of untreated or IL-4-stimulated CD1a/cþ DCs and CD14þ dDCs was measured by intracellular presence of DENV-E protein. The percentage of
DENV-Eþ cells is indicated. The graph depicts the collective data for each donor, represented by a symbol. Horizontal bars are the mean values. (c) Microscopic
detection of DENV-E protein in a CD14þ dDC but lacking from a neighboring CD1a/cþ DC. Scale bar¼ 10mm. The image is representative of two donors.
(d) Expression of DC-SIGN by CD1cþ and CD14þ dDCs emigrating from skin explants with or without IL-4. The graphs depict the mean fluorescence
intensity of DC-SIGN and mannose receptor expression for both subsets for each donor. The mean value is shown as horizontal bars. Statistical significance
was determined by unpaired Student’s t-test. *Po0.05; ***Po0.001.
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stimulatory capacity of dDCs (Figure 5c). To better assess the
consequences of DENV infection for the T-cell immune
response, we also measured naive T-cell proliferation induced
by infected dDCs. We found that infection further stimulates
T-cell activation (Figure 5d). As dMs are poor naive T-cell
stimulators (Haniffa et al., 2009) and remain within the tissue,
we cultured them together with total blood CD4þ T cells that
include memory T cells. Proliferation induced by untreated
dMs was low, but IL-4 and IL-4/GM-CSF converted the cells
into better T-cell stimulators (Figure 5e). Taken together, these
results predict that the major consequence of DENV infection
of dDCs would be a potent virus-directed T-cell response,
whereas DENV-infected dMs would principally fuel the local
inflammatory reaction.
DISCUSSION
Although dDCs and dMs reside in the most arbovirus-exposed
tissue and are equipped with pattern recognition receptors
such as C-type lectins (Harman et al., 2013; Ochoa et al.,
2008; Turville et al., 2002), the question of their role in patho-
gen entry and disease progression has been little explored. We
addressed this question using the dengue pathogen, because
(i) the virus is inoculated into the skin by mosquitoes, (ii) it
recognizes DC-SIGN and MR lectins, and (iii) the early infec-
tion events are likely to have a profound effect on progression
to life-threatening disease. In this report, we have shown that
CD1cþ and CD14þ dDCs as well as dMs are primary cell
targets for DENV and that IL-4 has an outstanding influence on
their viral infection and the immune response.
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To determine whether DENV infects the two distinct dDC
subsets, we adopted an unbiased approach by exposing
dermal emigrants to DENV, followed by FACS analysis. Both
CD1cþ and CD14þ dDCs were infected by DENV and the
latter often yielded a higher viral load, probably as a result of
increased DC-SIGN and MR expression. The finding that LCs
were poorly infected supports previous observations using
in vitro generated LCs (Lozach et al., 2005) and further
highlights the importance of the dermal antigen presenting
cells in DENV infection. When stimulated with IL-4, CD14þ
dDCs infection reached levels as high as 90%, correlating with
greatly upregulated DC-SIGN and MR levels. We could not
detect a significant production of TNF-a by dDCs, irrespective
of activation by IL-4, in line with other reports that failed
to observe TNF-a production by either CD1cþ or CD14þ
dDCs in response to a wide range of stimuli (Haniffa et al.,
2009; Haniffa et al., 2012). Instead, the consequences of
DENV infection of dDCs are most likely pathogen transport to
draining lymph nodes and the priming of virus-specific T cells.
This would lead to an anti-viral adaptive immune response,
considered a key event in dengue pathologies (Rothman and
Ennis, 1999). In view of the findings that CD14þ dDCs skew
the immune response to humoral immunity (Klechevsky et al.,
2008; Matthews et al., 2012), a privileged infection of the
CD14þ subset would result in an enhanced antibody-
mediated immune response. It is believed that a humoral
response heightens the risk of immunopathology during a
secondary infection with a heterotypic DENV serotype
(Halstead and O’Rourke, 1977). It is therefore tempting to
speculate the existence of a positive feedback loop between
CD14þ dDC infection and humoral immunity that becomes
relevant with repetitive DENV infections and may provide an
understanding into the increased risk of disease development
with multiple viral exposures.
Because of an absence of DC-SIGN and MR expression by
dMs after their purification from the skin and in keeping with
the idea that skin inflammation is likely to affect the suscepti-
bility of dermal immune cells to infection, we found a
prominent effect of IL-4, reinforced by GM-CSF, on DC-SIGN
and MR expression by dMs. This also demonstrates an
unexpected plasticity of dMs. dMs and CD14þ dDCs share
a number of phenotypic markers, and recent findings have
shown that CD14þ dDCs should be considered as an inter-
mediate phenotype between monocytes and Ms (McGovern
et al., 2014). Despite this distinction, the CD14þ cells that we
purified from digested dermis formed a homogeneous
population with characteristic features of Ms. This suggests
that CD14þ dDCs might have differentiated into Ms during
ex vivo culture, possibly under the influence of dermal
fibroblasts (Chomarat et al., 2000). This plasticity further
extends recent views on the ontogenic proximity of CD14þ
dDCs and monocytes (McGovern et al., 2014). IL-4-treated Ms
and CD14þ dDCs show characteristics shared with DCs
generated from blood monocytes with GM-CSF and IL-4
in vitro––i.e., downregulation of CD14 and increased
expression of DC-SIGN––although we did not observe
upregulation of CD1a in the dermis or in a culture with IL-4
and GM-CSF. Furthermore, the greater susceptibility to DENV
infection upon differentiation of CD14þ dermal cells is also
reminiscent of previous studies comparing monocytes exposed
or not to IL-4 (Miller et al., 2008).
As can be expected from the levels of the lectins, together
with their active cytoplasm, reflecting intensive endocytosis
and biosynthesis, IL-4-activated dMs were clearly permissive
to DENV infection. Infected dMs produced high levels of
TNF-a, which is thought to be the key cytokine for the
development of dengue fever (Green and Rothman, 2006;
Pang et al., 2007). Considering their limited ability of T-cell
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donors are shown, and the mean values are horizontal bars. (c) Proliferation of
naive CD4þ T cells by allogeneic DCs obtained from the skin with or without
IL-4. T-cell proliferation was measured as the loss of carboxyfluorescein
succinimidyl ester (CFSE) fluorescent dye. The data are representative of three
donors. (d) Proliferation of naive CD4þ T cells by allogeneic DCs obtained
from the skin with or without IL-4 and exposed to DENV. T-cell proliferation
was measured with CFSE, and the data are representative of three donors.
(e) Proliferation of CD4þ T cells by allogeneic dMs cultured in the indicated
conditions. T-cell proliferation was measured as the loss of CFSE. The data
are representative of three donors. Statistical significance was determined
by unpaired Student’s t-test. *Po0.05; **Po0.01; ***Po0.001;
NS, nonsignificant.
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priming compared with dDCs, even when activated by IL-4,
we propose that the principal contribution of dMs in dengue
disease lies in inflammation with systemic and local
consequences: (i) systemic activation of the immune system
promoting dengue fever and (ii) local inflammation resulting
in recruitment of immune cells, including lectin-expressing
dMs and dDCs, as well as memory T cells. Therefore, dM-
released TNF-a would fuel skin inflammation initiated by the
response to insect-derived salivary compounds and thus
would propel a loop that would render the skin highly
vulnerable to infection. Although studies in animal models
have revealed a major impact of mosquito saliva and their
immune stimulatory action on infectivity and viral
pathogenesis (Cox et al., 2012; Styer et al., 2011), so far no
correlation has been made in humans between hyper-
sensitivity and pathogenesis of arbovirus. Our finding that
skin dermatitis resembling reactions to mosquito bites leads to
a massive increase in CD163þ dDCs or dMs that maintain
DC-SIGN expression, taken together with the demonstration
that these cells are infectious targets, provides a first
experimental basis for such a correlation in man.
By investigating how DENV is handled by resident dermal
immune cells, we have uncovered a number of checkpoints
that are likely to affect early on the pathogenesis of arboviruses
in general and DENV in particular. The results also reveal that
therapeutic or prophylactic action, such as interference with
lectin binding and IL-4 producing reactions, would be effica-
cious at the skin level to prevent systemic spread of the virus
and immunopathology.
MATERIALS AND METHODS
Purification of skin cells
Abdominal skin was obtained with written informed consent and
institutional review board approval, in agreement with the Helsinki
Declaration and French legislation. DCs were isolated by floating
whole skin pieces for 3 days onto complete medium lacking or
containing IL-4 (25 ng ml 1; Nestle et al., 1993). For dMs purifi-
cation, the epidermis was removed after trypsin digestion (0.5% in
phosphate-buffered saline) and the remaining dermis digested with
collagenase and DNAse for 18 hours (Angel et al., 2006; Zaba et al.,
2007). The cell suspension was cultured in complete medium for 48
hours in the absence or presence of IL-4 (25 ng ml 1), and adherent
and non-adherent CD14þ cells were first positively enriched with
magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany)
before flow cytometric sorting. Sorted CD14þ cells were allowed
to recover for 24 hours in complete culture medium conditioned by
dermal fibroblasts in the absence or presence of IL-4 (25 ng ml 1) or
GM-CSF (25 ng ml 1) before infection.
Cell phenotype analyses
The phenotypes of dDCs and dMs were analyzed using the following
antibodies from BD Biosciences (Franklin Lakes, NJ): HLA-DR-FITC
(Tu¨39 or L243), MR/CD206-FITC (19.2), DC-SIGN/CD209-PerCP-
Cy5.5 (DCN46), CD1a-APC (HI149), CD86-FITC (FUN-1), as well as
CD14-PE (MEM-15, ImmunoTools, Friesoythe, Germany) and CD1c-
APC (AD5-8E7, Miltenyi Biotec). Cells were analyzed on FACSCali-
bur (BD Biosciences) or Gallios (Beckman-Coulter, Brea, CA) after
exclusion of dead cells by Sytox Red (Molecular Probes, Invitrogen,
Grand Island, NY), 7AAD (BD Biosciences) or Fixable Viability Dye-
eBio 780 (eBioscience). Data were analyzed using the Cell Quest Pro
software (BD Biosciences), Kaluza (Beckman-Coulter), or FlowJo
(TreeStar, Ashland, OR).
DENV production
The pDENV-2 replicon of DENV-2 16681 (5mg; gift of Dr. E. Harris,
University of California, Berkeley, CA) was linearized, phenol–
chloroform extracted, precipitated, and resuspended in RNase-free
water. RNA was synthesized by in vitro transcription using the T7
RiboMax Large scale RNA production Systems (Promega, Madison,
WI) with additional 7 mG(ppp)A RNA Cap Structure Analog (New
England BioLabs, Ipswich, MA). The RNA was transfected into BHK-
21 (106 cells per well) in a six-well plate using the Lipofectamine
RNAiMax kit (Invitrogen): 50ml RNA mixture in 200ml Opti-MEM
was added to 50ml Lipofectamine in 200ml Opti-MEM (Life-Tech-
nologies, Grand Island, NY), incubated for 20 minutes and added to
106 cells. After 3 hours, the supernatant was removed and cells were
cultured in complete Glasgow MEM medium. Supernatants were
collected, spun down to remove cells, and stored in aliquots at
 80 1C. DENV-2 was produced in C6/36 Aedes albopictus mosquito
cells, maintained in Leibovitz L15 medium, by infection with viral
supernatants of BHK-21 cells. C6/36 cell supernatants were collected
and stored in aliquots at  80 1C.
DENV infections
Skin-purified cells (0.5 105 cells) were exposed to DENV serotype 2
(strain 16681) at a multiplicity of infection of 0.5. After incubation for
2 hours at 37 1C in serum-free medium, cells were washed and
cultured in complete medium. After 2 days, cells were subjected to
intracellular detection of the viral E protein.
Infection analysis
Cells were fixed with 4% (v/v) paraformaldehyde and permeabilized
with 0.1% (v/v) Triton X-100 for 3 minutes at room temperature. After
washing, they were labeled with mouse anti-DENV-E protein mAb
(IgG1, 3H5-1, Millipore, Molsheim, France), followed by APC-anti-
mouse IgG1 (BD Biosciences). We stained with anti-CD14 (AB383)
followed by donkey anti-goat IgG-AlexaFluor488 (Molecular Probes,
Invitrogen), anti-HLA-DR-PerCP (L243) and, where indicated, anti-
DC-SIGN-AlexaFluor488 (111H2 IgG2b, Dendritics, Lyon, France).
For analyses of LC infection among total crawlout cell suspensions,
we combined anti-DC-SIGN-PerCP-Cy5.5 (DCN46), anti-Langerin/
CD207-PE (DCGM4, Dendritics), anti-HLA-DR-AlexaFluor700 (L203,
R&D Systems, Minneapolis, MN), and Fixable Viability Dye-eBio780
(eBioscience, San Diego, CA). Fluorescence was measured by flow
cytometry (FACSCalibur, BD Biosciences or Gallios, Beckman-Coul-
ter), and the data analyzed using the Cell Quest Pro or FlowJo
software. Titers in cell-free supernatants were determined by infection
of Vero cells as previously described (Lambeth et al., 2005).
Cytokine production
Two days after infection, cell supernatants were collected, and TNF-a
was measured by ELISA (OptEIA, BD Biosciences).
T-cell stimulation assay
Graded doses of purified dMs or total skin crawlout cells were
incubated with 5 104 carboxyfluorescein succinimidyl ester (CFSE)-
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loaded total blood T cells or 105 naive CD4þ T cells purified from
peripheral blood by negative selection (Miltenyi Biotec), respectively,
in 96-well round-bottom plates in complete medium. After 5-day
incubation, the cells were labeled for CD3 and CD4 and analyzed by
flow cytometry for CFSE dilution in the CD3þ CD4þ gate. Prolifera-
tion was determined as the proportion of T cells with decreased
intensity of CFSE.
Total skin crawlout cells were infected with DENV-2 for 2 days, and
then graded doses were incubated with 105 CFSE-loaded naive CD4þ
T cells in 96-well plates in complete medium. After 5-day incubation,
the cells were labeled with fixable viability dye-eBio780 and anti-
CD3-AF700 (BD Biosciences). Live T cells (CD3þ fixable viability
dye-negative) were analyzed by flow cytometry for CFSE dilution.
Skin sections
Formol-fixed skin sections were cut and prepared for labeling with
anti-CD163 mAb 10D6 and anti-DC-SIGN mAb 111H2 (Canard
et al., 2011; Dendritics). Counter staining was carried out with DAPI
(40,6-diamidino-2-phenylindole). For diseased skins, two areas in the
upper dermis and one in the reticular dermis were selected. Labeled
cells were counted manually in three non-superimposable optical
fields of 0.125 mm2 using a computer-assisted image analysis Image J
freeware.
Confocal and electron transmission microscopy
A total of 5 104 cells per chamber were cultured on poly-
lysine-coated slides (eight chamber Nunc Lab-Tek, Dutscher, Bru-
math, France) for 2 hours without serum, with or without DENV. Cells
were collected and washed three times in complete medium before
adding them back to the chamber. After 48 hours, the cells were fixed
and labeled for DENV-E protein using Cy3-conjugated mAb 4G2
(kind gift from Dr. Philippe Despres, Institut Pasteur, Paris, France)
together with PerCP-anti-HLA-DR (L243) and anti-CD14 (AB383,
R&D Systems) followed by Alexa 488-donkey anti-goat (Molecular
Probes, Invitrogen). DAPI was used as nuclear counterstaining. Slides
were mounted using Fluromount (Dako, Les Ulis, France). Images
were taken on Zeiss LSM 780 (Carl Zeiss, Jena, Germany) with GaAsP
detector and Zen acquisition software (Zeiss). Images were further
processed using the Image J freeware. Electron microscopy was
performed as previously described (Kwan et al., 2008).
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